First ever successful Ebola virus vaccine is developed by Chinese company. It has passed phase one testing in initial trials. Tianjin CanSino and Beijing Institute of Biotechnology has jointly formulated vaccines against Ebola virus. Their joint product is based on Ebola virus which was picked from African Zaire epidemic disease. Virus was named adenovirus type-5.
Chinese firm said that current version of vaccine is much easier to handle and store. It can be transported from one place to another very comfortably using any transportation medium.
Biotechnology scientists have taken 120 volunteers for phase one testing. They all were given doze of various quantity. Some with high doze and other low doze. Experiment was done in Taizhou County of Jiangsu Province.
Scientists have put all those under care. More than 95% with low doze have been proved with successful immune system development against Ebola virus. Those who were given high doze have been proved 100% results for virus protection.
Related Stories:
Chinese firm said that current version of vaccine is much easier to handle and store. It can be transported from one place to another very comfortably using any transportation medium.
Biotechnology scientists have taken 120 volunteers for phase one testing. They all were given doze of various quantity. Some with high doze and other low doze. Experiment was done in Taizhou County of Jiangsu Province.
Scientists have put all those under care. More than 95% with low doze have been proved with successful immune system development against Ebola virus. Those who were given high doze have been proved 100% results for virus protection.
Related Stories:
